PROMETHERA Biosciences S.A./N.V.

BiotechnologySeries DBelgiumpromethera.com

Latest round

Series D

Last raised

Dec 2019

Total raised

$69M

Investors

26

About PROMETHERA Biosciences S.A./N.V.

V. operates as a biosciences firm that offers cell therapy research. The company was founded by Etienne Sokal.V., Ltd, and Six Snow. The firm develops stem cell treatments for patients and helps them by restoring liver health. It helps patients in need of liver transplantation by providing a potential alternative to transplantation or helps them by gaining more time till transplant by stabilizing disease progression. It offers cell-therapy treatment, HepaStem™ which provides anti-fibrotic, anti-inflammatory, and immunomodulatory benefits.

Who invested in PROMETHERA Biosciences S.A./N.V.

26 investors across 6 rounds

See all investors in PROMETHERA Biosciences S.A./N.V.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series D

    Dec 16, 2019

    Amount

    $7.8M

    Investors

    Locked

  2. Series D

    May 16, 2019

    Amount

    $13M

    Investors

    Locked

  3. Series C

    Nov 14, 2016

    Amount

    $11M

    Investors

    Locked

  4. Series C

    Dec 9, 2014

    Amount

    $7.5M

    Investors

    Locked

  5. Series B

    Apr 16, 2012

    Amount

    $22M

    Investors

    Locked

  6. Series A

    Nov 12, 2009

    Amount

    $7.9M

    Investors

    Locked

Questions about PROMETHERA Biosciences S.A./N.V.

Who invested in PROMETHERA Biosciences S.A./N.V.?

PROMETHERA Biosciences S.A./N.V. has 26 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has PROMETHERA Biosciences S.A./N.V. raised?

PROMETHERA Biosciences S.A./N.V. has raised 6 venture rounds. Sign up free to see how much each round raised and the total.

When did PROMETHERA Biosciences S.A./N.V. last raise money?

PROMETHERA Biosciences S.A./N.V.'s most recent round on record is a Series D, in Dec 2019.

What does PROMETHERA Biosciences S.A./N.V. do?

PROMETHERA Biosciences S.A./N.V. is a biotechnology company.

Where is PROMETHERA Biosciences S.A./N.V. headquartered?

PROMETHERA Biosciences S.A./N.V. is headquartered in Belgium.

Which VCs invest in companies like PROMETHERA Biosciences S.A./N.V.?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at PROMETHERA Biosciences S.A./N.V.'s stage. Their profiles are linked below.

Raising like PROMETHERA Biosciences S.A./N.V.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.